GeneDx Holdings Corp. WGSWW
Set alert
0.00 USD 0.00 0.00%
At close · Jul 22
0.00 0.00 +1,350.00%
After hours · Jul 22, 4:00 PM ET
0.0002 Day range 0.0002
0.0002 52-week range 0.0012
- YTD
- -98.00%
- 1 year
- -98.00%
- Open
- 0.0002
- Prev close
- 0.0002
- Mkt cap
- 5.79K
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0002
- High
- 0.0002
- Forward P/E
- 0.00
- Beta
- 1.91
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 1.91
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -17.58%
- Revenue (TTM)
- 442.68M
- Revenue growth
- 17.40%
- Free cash flow
- -38.86M
- Total cash
- 170.69M
- Total debt
- 168.19M
- Return on equity
- -30.42%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 3, 2026 | Jun 30, 2026 | -0.1875 | -0.60 | -0.41 | -220.00% |
| May 4, 2026 | Mar 31, 2026 | -0.015 | -0.28 | -0.26 | -1,766.67% |
| Feb 23, 2026 | Dec 31, 2025 | 0.1023 | 0.14 | +0.04 | +36.85% |
| Oct 28, 2025 | Sep 30, 2025 | 0.4229 | 0.49 | +0.07 | +15.87% |
| Jul 29, 2025 | Jun 30, 2025 | 0.1158 | 0.50 | +0.38 | +331.78% |
| Apr 30, 2025 | Mar 31, 2025 | 0.05912 | 0.2752 | +0.22 | +365.49% |
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
- Country
- United States
- Employees
- 1,300
- Website
- genedx.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on WGSWW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| LMR Partners LLP | 14.47% | 2,135,439 | 3.84K | Mar 30, 2026 |
| Shaw D.E. & Co., Inc. | 3.17% | 467,197 | 840 | Mar 30, 2026 |
| Price (T.Rowe) Associates Inc | 1.65% | 243,780 | 438 | Mar 30, 2026 |
| Q Global Advisors, LLC | 0.76% | 111,701 | 201 | Mar 30, 2026 |
| Toronto Dominion Bank | 0.72% | 105,950 | 190 | Mar 30, 2026 |
| Wolverine Asset Management, LLC | 0.40% | 58,876 | 105 | Mar 30, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 1.40% | 206,747 | 372 | Mar 30, 2026 |
| T. ROWE PRICE Eqy. SERIES, INC.-T. Rowe Price Health Sciences PORT. | 0.08% | 11,396 | 20 | Mar 30, 2026 |
| John Hancock Variable Insurance Trust-Health Sciences Trust | 0.03% | 4,862 | 8 | Mar 30, 2026 |
| EQ Advisors Trust-EQ/T. Rowe Price Health Sciences Portfolio | 0.02% | 3,332 | 5 | Mar 30, 2026 |